Durable Response to Pazopanib in a Patient with Fumarate Hydratase-Mutant Tubulocystic Renal Cell Carcinoma
Sign Up to like & getrecommendations! Published in 2023 at "Case Reports in Oncology"
DOI: 10.1159/000528697
Abstract: Abstract Tubulocystic carcinoma of the kidney (TC-RCC) is a rare renal tumor and has been recently included as a distinct entity in WHO classification of renal neoplasms. We report the case of a patient with… read more here.
Keywords: response pazopanib; fumarate hydratase; durable response; carcinoma ... See more keywords
Pulmonary carcinosarcoma showing an obvious response to pazopanib: a case report
Sign Up to like & getrecommendations! Published in 2018 at "BMC Pulmonary Medicine"
DOI: 10.1186/s12890-018-0757-7
Abstract: BackgroundPulmonary carcinosarcoma (PCS) is a rare primary lung malignancy and has a poor prognosis among lung tumor histological subtypes. However, an appropriate treatment strategy has not been developed for unresectable PCS.Case presentationA 65-year-old man who… read more here.
Keywords: pazopanib; response pazopanib; response; case ... See more keywords